The Orphan Therapeutics Accelerator (OTXL), a non-profit biotech organization focused on completing development and ...

Preclinical Isolated Organ Perfusion System Market is projected to grow through 2035, Driven by demand for precise drug testing and less animal use ...

and scientific advisory company that provides biotech and small- to mid-sized pharma companies an accelerated path to market, has been recognized as the Best Contract Research Organization in ...

Far-right activist Laura Loomer has spoken with Trump administration officials about utilizing her opposition research firm to ... Office in a bid to obtain a contract to vet Trump administration ...

While Big Pharma is showing improved momentum, the contract research organization market remains challenged as biotech venture capital funding remains relatively soft. We expect biotech venture ...

a premier Australian contract research organization (CRO). This collaboration will accelerate Psyence BioMed's ongoing Phase IIb psilocybin clinical trial in Australia, which focuses on adjustment ...

the U.S. Food and Drug Administration told an unspecified number of drug companies that studies used to support therapeutic equivalence of some of their medicines have been rejected due to false data ...

The agency identified “significant” problems with data integrity and the way studies were conducted by Raptim Research, which had been hired by the drugmakers to test their medicines.

Under this new contract, the provider will introduce ... our reach and enhances public safety outcomes in a notable U.S. market," commented Ordan Trabelsi, President and CEO of SuperCom.

NETSOL Technologies, Inc. (NASDAQ:NTWK), a provider of solutions for the asset finance and leasing industry with a market capitalization of $27.54 million, has secured a contract with a Chinese ...

Leidos is battling for a second chance at keeping a long-term contract worth up to $89 billion over 25 years to support the National Cancer Center. The contract dates to the old Science ...